Showing 821 - 840 results of 933 for search '"virology"', query time: 0.06s Refine Results
  1. 821

    Efficacy of pegylated interferon alfa-2b «Algeron» in the treatment of chronic hepatitis C by M. V. Mayevskaya, O. O. Znoyko, E. A. Klimova, S. L. Maximov, S. N. Kizhlo, N. A. Petrochenkova, F. I. Nagimova, R. A. Ivanov, Yu. N. Linkova, T. V. Chernovskaya

    Published 2013-03-01
    “…Primary efficacy endpoints were rapid and early virologic response (RVR and EVR).Results. Comparative analysis of virologic response rate after 4th and 12th weeks of the therapy and biochemical response did not show any statistically significant differences between the groups. …”
    Get full text
    Article
  2. 822

    Combined Treatment with Antiviral Therapy and Rituximab in Patients with Mixed Cryoglobulinemia: Review of the Literature and Report of a Case Using Direct Antiviral Agents-Based A... by Teresa Urraro, Laura Gragnani, Alessia Piluso, Alessio Fabbrizzi, Monica Monti, Elisa Fognani, Barbara Boldrini, Jessica Ranieri, Anna Linda Zignego

    Published 2015-01-01
    “…Here, we report a complete remission of MC after a sustained virological response following a combined RTX/Peg-IFN+RBV+DAA (boceprevir) treatment and review the literature about the combined RTX/AT.…”
    Get full text
    Article
  3. 823

    Avian influenza annual report 2023 by European Food Safety Authority (EFSA), José Cortiñas Abrahantes, Inma Aznar, Iancu Catalin, Lisa Kohnle, Kenneth Fergus Mulligan, Lina Mur, Anca Stoicescu, Aniek vanHoutum, Gabriele Zancanaro

    Published 2025-01-01
    “…Of the 2626 PEs sampled for virological testing, 180 PEs (6.85%) were positive for influenza A(H5/H7) viruses. …”
    Get full text
    Article
  4. 824

    Protease Inhibitor Resistance Is Uncommon in HIV-1 Subtype C Infected Patients on Failing Second-Line Lopinavir/r-Containing Antiretroviral Therapy in South Africa by Carole L. Wallis, John W. Mellors, Willem D. F. Venter, Ian Sanne, Wendy Stevens

    Published 2011-01-01
    “…This study examined drug resistance patterns emerging in 75 HIV-1 infected adults experiencing virologic failure on a second-line regimen containing 2 NRTI and lopinavir/ritonavir. …”
    Get full text
    Article
  5. 825

    Investigation of west nile virus infection in brown bears (ursus arctos) in turkey by Yakup Yıldırım, Fethiye Çöven, Erdoğan Uzlu, Volkan Yılmaz, Emrah Çoban, Ayşegül Çoban, Çağan Hakkı Şekercioğlu

    “…<b>Aim:</b> This study is a serological and virological examination of the West Nile Virus (WNV) in free-ranging brown bears (Ursus arctos) in Sarikamis district of Kars province of Turkey.…”
    Get full text
    Article
  6. 826

    Antiretroviral Therapy for HIV-2 Infection: Recommendations for Management in Low-Resource Settings by Kevin Peterson, Sabelle Jallow, Sarah L. Rowland-Jones, Thushan I. de Silva

    Published 2011-01-01
    “…Nucleoside analogues alone are not sufficiently potent enough to achieve durable virologic control. Some protease inhibitors, in particular those without ritonavir boosting, are not sufficiently effective against HIV-2. …”
    Get full text
    Article
  7. 827

    Long-Term Real-World Outcomes of Tenofovir Alafenamide in Chronic Hepatitis B: Detailed Analysis of Treatment-Naive and Experienced Patients by Yu-Xuan Song, Guang-Jun Song, Hui Ma, Bo Feng, Yan-Di Xie

    Published 2025-01-01
    “…In treatment- naive patients, the rates of a virological response, HBeAg conversion, and HBsAg loss at 192 weeks were 100%, 33.3%, and 2%, respectively. …”
    Get full text
    Article
  8. 828

    Multiple fusiform and saccular aneurysms in a person living with Human Immunodeficiency Virus by Talia Unice, Poobalan Naidoo, Pranav Hiralal, Yeshkhir Naidoo, Somasundram Pillay

    Published 2023-11-01
    “…We report on a 21-year-old male with human immunodeficiency virus infection and suboptimal virological control, despite highly active antiretroviral therapy. …”
    Get full text
    Article
  9. 829

    An Update on the Management of Chronic Hepatitis C: 2015 Consensus Guidelines from the Canadian Association for the Study of the Liver by Robert P Myers, Hemant Shah, Kelly W Burak, Curtis Cooper, Jordan J Feld

    Published 2015-01-01
    “…Specifically, direct-acting antiviral agents with dramatically improved rates of virological clearance compared with standard therapy have been developed and interferon-free, all-oral antiviral regimens have been approved. …”
    Get full text
    Article
  10. 830

    Management of the Kidney Transplant Patient with Chronic Hepatitis C Infection by Ignatius Y. S. Tang, Natasha Walzer, Nidhi Aggarwal, Ivo Tzvetanov, Scott Cotler, Enrico Benedetti

    Published 2011-01-01
    “…Achievement of sustained virological response (SVR) may reduce the risks for both posttransplantation hepatic and extrahepatic complications such as de novo or recurrent glomerulonephritis associated with HCV. …”
    Get full text
    Article
  11. 831

    Postinfantile Giant Cell Hepatitis with Features of Acute Severe Autoimmune Hepatitis Probably Triggered by Diclofenac in a Patient with Primary Myelofibrosis by Pinelopi Arvaniti, Kalliopi Zachou, George K. Koukoulis, George N. Dalekos

    Published 2018-01-01
    “…After careful exclusion of other hepatitis causes by imaging, virological, immunological, and microbiological investigations, a diagnosis of acute severe AIH (AS-AIH) was established. …”
    Get full text
    Article
  12. 832

    An Update on the Management of Chronic Hepatitis C: Consensus Guidelines from the Canadian Association for the Study of the Liver by Robert P Myers, Alnoor Ramji, Marc Bilodeau, Stephen Wong, Jordan J Feld

    Published 2012-01-01
    “…Specifically, direct-acting antiviral agents with dramatically improved rates of virological clearance compared with standard therapy have been developed, and several single nucleotide polymorphisms associated with an increased probability of spontaneous and treatment-induced viral clearance have been identified. …”
    Get full text
    Article
  13. 833

    Traceback and Testing of Food Epidemiologically Linked to a Norovirus Outbreak at a Wedding Reception by Efstathia Papafragkou, Amanda Kita-Yarbro, Zihui Yang, Preeti Chhabra, Timothy Davis, James Blackmore, Courtney Ziemer, Rachel Klos, Aron J. Hall, Jan Vinjé

    Published 2025-01-01
    “…In conclusion, this comprehensive norovirus outbreak investigation combined epidemiologic, virologic, and environmental findings to traceback the contaminated food as the source of the outbreak.…”
    Get full text
    Article
  14. 834

    HIV-1 Trans Infection of CD4+ T Cells by Professional Antigen Presenting Cells by Charles R. Rinaldo

    Published 2013-01-01
    “…The end result is that HIV-1 can sequester within the APC for several days and be transmitted via membrane extensions intracellularly and extracellularly to T cells across the virologic synapse. Virus replication requires activated T cells that can develop concurrently with the events of virus transmission. …”
    Get full text
    Article
  15. 835

    Imaging flow cytometry reveals the mechanism of equine arteritis virus entry and internalization by Agata Kublicka, Daria Lorek, Agata Mikołajczyk-Martinez, Grzegorz Chodaczek, Aleksandra Chwirot, Barbara Bażanów, Anna Karolina Matczuk

    Published 2025-01-01
    “…Imaging flow cytometry, which integrates the advantages of both methodologies, offers significant potential in virological studies. In this investigation, we employed imaging flow cytometry coupled with immunostaining to monitor the entry of equine arteritis virus EAV into Vero cells via the endosomal trafficking route. …”
    Get full text
    Article
  16. 836

    Simeprevir and Sofosbuvir Combination Treatment in a Patient with HCV Cirrhosis and HbS Beta 0-Thalassemia: Efficacy and Safety despite Baseline Hyperbilirubinemia by Nikolaos Papadopoulos, Melanie Deutsch, Athanasios Georgalas, Helias Poulakidas, Lazaros Karnesis

    Published 2016-01-01
    “…Hyperbilirubinemia was benign and fully reversible and our patient finally achieved sustained virological response 24 weeks after the end of treatment.…”
    Get full text
    Article
  17. 837

    The Need for Development of New HIV-1 Reverse Transcriptase and Integrase Inhibitors in the Aftermath of Antiviral Drug Resistance by Mark A. Wainberg

    Published 2012-01-01
    “…The use of highly active antiretroviral therapy (HAART) involves combinations of drugs to achieve maximal virological response and reduce the potential for the emergence of antiviral resistance. …”
    Get full text
    Article
  18. 838

    Pegilated interferon alpha 2b «Pegaltevir» chronic hepatitis C treatment (randomized clinical trial) by Marina V. Mayevskaya, Ye. N. Bessonova, P. O. Bogomolov, N. I. Geyvandova, K. V. Zhdanov, V. G. Morozov, V. D. Pasechnikov, I. Yu. Khomenko, A. V. Yagoda, V. T. Ivashkin

    Published 2018-08-01
    “…Assessment of Pegaltevir® efficacy was carried out in 4 weeks (rapid virologic response, RVR) and 12 weeks of treatment (early virologic response, EVR) in groups 1 and 3 in comparison to corresponding scores in groups 2 and 4 (primary criteria of efficacy were estimated in all 140 patients enrolled in original study. …”
    Get full text
    Article
  19. 839

    Disease burden of influenza in Spain: A five-season study (2015–2020) by Iván Sanz-Muñoz, Irene Arroyo-Hernantes, Alejandro Martín-Toribio, Marina Toquero-Asensio, Javier Sánchez-Martínez, Carla Rodríguez-Crespo, Silvia Rojo-Rello, Marta Domínguez-Gil, Marta Hernández-Pérez, Eduardo Tamayo, Ruth Gil-Prieto, Ángel Gil-de-Miguel, José M Eiros

    Published 2025-12-01
    “…In this period, approximately 7.8% of those hospitalized required ICU admission, and 5.7% died in the hospital due to influenza, with wide differences in these parameters depending on the season due to the virological characteristics of the major circulating viruses. …”
    Get full text
    Article
  20. 840

    Type B non-Hodgkin lymphoma in a patient with acquired immunodeficiency virus with no detected viral load. Case report by Edwin Marcelo Miranda Solìs, Juan Fernando Orozco Herrera

    Published 2023-07-01
    “…For these reasons, we present the case of a 58-year-old patient, diagnosed with acquired immunodeficiency virus in the year 2000, who in the last ten years presented adequate clinical, virological, and pharmacological control. Suddenly and a few months ago, he began with symptoms related to a spinal cord compression syndrome at the lumbar level characterized by pain, functional impotence of the extremities and paresthesias. …”
    Get full text
    Article